Navigation Links
Mesa Labs Reports Higher Quarterly Sales and Earnings
Date:11/7/2007

ear ended March 31, 2007 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.

FINANCIAL SUMMARY

STATEMENT OF EARNINGS (Unaudited)

Quarter Ended Six Months Ended

September 30 September 30

2007 2006 2007 2006

Net Sales $4,868,000 $4,186,000 $9,154,000 $7,860,000

Cost of Goods 1,583,000 1,506,000 2,968,000 2,793,000

Gross Profit 3,285,000 2,680,000 6,186,000 5,067,000

Operating Expense 1,363,000 1,281,000 2,750,000 2,473,000

Operating Income 1,922,000 1,399,000 3,436,000 2,594,000

Other (Income) &

Expense (49,000) (29,000) (96,000) (69,000)

Earnings Before Taxes 1,971,000 1,428,000 3,532,000 2,663,000

Income Taxes 692,000 516,000 1,238,000 961,000

Net Income $1,279,000 $912,000 $2,294,000 $1,702,000

Earnings Per Share

(Basic) $.40 $.29 $.72 $.54

Earnings Per Share

(Diluted) $.39 $.28 $.70 $.53

Average Shares

(Basic) 3,169,000 3,174,000 3,170,000 3,154,000

Average Shares

(Diluted) 3,288,000 3,260,000 3,289,000 3,229,000

BALANCE SHEETS (Unaudited)

Sept. 30 March 31

2007 2007

Cash and Short-term

Investments $4,722,000 $3,346,000

Other Current Assets 7,364,000 7,496,000

Total Current Assets 12,086,000 10,842,000

Property and Equipment 3,484,000
'/>"/>

SOURCE Mesa Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...es of chronic pain. Many people are immobilized an...now there’s good news for the long-suffering arthr...st popular forms of alternative medicine, is suppo...hose suffering from arthritis. A team led by Dr. J...
...ew York on Thursday, at an American Medical Associ...y cooling people whose hearts have suddenly stoppe...without organ damage. Dr. Lance B. Becker, Directo...at the University of Chicago said that thousands o...
...nal Epidemiology, high levels of DDT found in some... male reproductive function. The human body metabo...hers took blood samples from 24 men aged 16 to 28 ... work. In these men the high DDE levels correlated...
...ion dollars to Johns Hopkins University in the Uni...e. This would be the world’s foremost center for m...s say the Johns Hopkins Malaria Institute will put...rts to find an effective vaccine and new treatment...
Other Medicine News:
(Date:10/6/2008)...a from SONIC Trial Showed REMICADE Therapy is More...osal Healing Compared with Standard ...., Oct. 6 /- Data presented for the f... Crohn,s Disease Naive to,Immunomodulators and Bio...o,the approach to care of patients with moderate t...
(Date:10/6/2008)...re than 60 percent of moderate to severe patients ...ent achieved endoscopic remission at Week 10,in da...e American College,of Gastroenterology (ACG) Annua...wswire/ -- UCB today presented data from a,large, ...ment in Crohn,s,disease (CD) with a biologic compo...
(Date:10/6/2008)...- TARGIT Procedure May Eliminate 6 Weeks of Radiat...Treatment over the Internet Wednesday, October ...ra.com/explorehealth , HAMPTON, Va., Oct. 6 /PRNe... when she was diagnosed with breast cancer in May....east? How about radiation or chemotherapy?, , To...
(Date:10/6/2008)...cent study revealed that drinking polyphenol-rich ...hanges in appetite, energy intake or body,weight, ...nsumption of 100%,polyphenol-rich Concord grape ju... associated with changes in appetite and was shown...ta presented at the 49th Annual Meeting of,the Ame...
Breaking Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3CellCyte Genetics Corp Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases 3175 1CellCyte Genetics Corp Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases 3175 2CellCyte Genetics Corp Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases 3175 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 1American Chemical Societys Weekly PressPac Feb 6 2008 11486 2American Chemical Societys Weekly PressPac Feb 6 2008 11486 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 5American Chemical Societys Weekly PressPac Feb 6 2008 11486 6American Chemical Societys Weekly PressPac Feb 6 2008 11486 7American Chemical Societys Weekly PressPac Feb 6 2008 11486 8American Chemical Societys Weekly PressPac Feb 6 2008 11486 9HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman 26 Friedman for 24575 Million 11481 1HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman 26 Friedman for 24575 Million 11481 2HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman 26 Friedman for 24575 Million 11481 3Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 1Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 2Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 3Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 4
..., 2007--The costs of eradicating,poliomyelitis fro...the short term, are much lower than the long term ...ication. And a recently developed,monovalent vacci...pe 1 poliomyelitis than an existing trivalent vacc...hed Online and in an upcoming,issue of The Lancet....
..., April 11, 2007 /PRNewswire-FirstCall/ --,Advance...two,additional Phase III clinical trials of ferumo...apeutic that are being,presented today at approxim...y Foundation,s Spring Clinical Meeting in Orlando,...tor section on the,company,s web site at <a target...
Other Medicine Technology:Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 2Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 3Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 4Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 5Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 6Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 7Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 8
MVR Blades for water tight self sealing incision.
Lens Plus Daily Cleaner is the preservative-free daily cleaner for soft contact lenses.
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro
Medicine Products: